ArticleslgStudy

science

Minhai COVID-19 vaccine

Minhai COVID-19 vaccine is a science topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Minhai COVID-19 vaccine rather than just read about it. In short: Minhai COVID-19 vaccine (Chinese: 康泰民海新冠疫苗), trademarked as KCONVAC (Chinese: 可维克; pinyin: Kěwéikè), is a COVID-19 vaccine developed by Shenzhen Kangtai Biological Products Co. Ltd and its subsidiary, Beijing Minhai Biotechnology Co., Ltd.

Minhai COVID-19 vaccine — main illustration
Minhai COVID-19 vaccine — illustration

Key takeaways

  • Minhai COVID-19 vaccine belongs to science; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect Minhai COVID-19 vaccine to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of Minhai COVID-19 vaccine from memory before moving on to harder problems.

Reference excerpt

Minhai COVID-19 vaccine (Chinese: 康泰民海新冠疫苗), trademarked as KCONVAC (Chinese: 可维克; pinyin: Kěwéikè), is a COVID-19 vaccine developed by Shenzhen Kangtai Biological Products Co. Ltd and its subsidiary, Beijing Minhai Biotechnology Co., Ltd.

Clinical trials In October 2020, KCONVAC started phase I clinical trials with 180 participants in China. Later, KCONVAC started phase II trials with 1,000 participants in China. In May 2021, KCONVAC started phase III trials for global trials with 28,000 participants.

Children and adolescents trials In August 2021, KCONVAC started phase I trials with 84 participants in China. In September, KCONVAC started phase II trials with 480 participants in China.

Authorizations

On 14 May 2021, the vaccine became the fourth inactivated Chinese Vaccine to be authorised for emergency use.

References

Illustrations

Minhai COVID-19 vaccine: Scientifically accurate atomic model of the external structure of SARS-CoV-2. Each "ball" is an atom.
Scientifically accurate atomic model of the external structure of SARS-CoV-2. Each "ball" is an atom.

Worked examples

Example 1 — a first encounter with Minhai COVID-19 vaccine

Start with the simplest possible case. Write down what Minhai COVID-19 vaccine claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In science, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Minhai COVID-19 vaccine before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Minhai COVID-19 vaccine ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Minhai COVID-19 vaccine

In research
Minhai COVID-19 vaccine appears in science research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses Minhai COVID-19 vaccine in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
Minhai COVID-19 vaccine is common in secondary-school and first-year university syllabi. It links to neighbouring topics COVID-19 vaccine stubs, Chinese COVID-19 vaccines, Inactivated vaccines, so understanding it makes those chapters shorter.
In everyday life
Look for Minhai COVID-19 vaccine outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.
Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Minhai COVID-19 vaccine” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Minhai COVID-19 vaccine in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what Minhai COVID-19 vaccine means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain Minhai COVID-19 vaccine out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Minhai COVID-19 vaccine in simple terms?

Minhai COVID-19 vaccine (Chinese: 康泰民海新冠疫苗), trademarked as KCONVAC (Chinese: 可维克; pinyin: Kěwéikè), is a COVID-19 vaccine developed by Shenzhen Kangtai Biological Products Co. Ltd and its subsidiary, Beijing Minhai Biotechnology Co., Ltd.

Why does Minhai COVID-19 vaccine matter?

Because it connects several science ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Minhai COVID-19 vaccine?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Minhai COVID-19 vaccine.

Tags

  • COVID-19 vaccine stubs
  • Chinese COVID-19 vaccines
  • Inactivated vaccines
  • Science and technology in China

Keep exploring